FDA inspection

R And D Laboratories Inc: FDA inspection ending Jul 7, 2000

FDA inspection 29592 · No Action Indicated (NAI) · Marina Del Rey, CA

Key facts

Inspection ID	29592
Firm	R And D Laboratories Inc
FEI number	2025433
Address	4640 Admiralty Way Ste 710
City	Marina Del Rey
State	CA
ZIP	90292-6639
Fiscal year	2000
Inspection end date	Jul 7, 2000
Classification	No Action Indicated (NAI)
Project area	Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs\|Post Mrkt Surv & Epid: Human Drugs
Product type	Drugs

At a glance

None Citations
None Posted citations
No Warning letter followed
Yes Form FDA 483 issued
No Establishment inspection report (EIR) exists
1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections